Valuation: Divi's Laboratories Limited

Market Cap 2,321B 24.35B 20.87B 19.55B 17.86B 33.7B 34.04B 231B 89.78B 1,171B 91.43B 89.44B 3,879B P/E 2027 *
71.4x
P/E 2028 * 59.1x
Enterprise Value 2,286B 23.98B 20.55B 19.26B 17.59B 33.2B 33.52B 227B 88.42B 1,154B 90.05B 88.09B 3,820B EV / Sales 2027 *
18.2x
EV / Sales 2028 * 15.2x
Free-Float
48.01%
Yield 2027 *
0.4%
Yield 2028 * 0.44%
1 day+3.21%
1 week+5.43%
Current month+12.03%
1 month+21.73%
3 months+33.64%
6 months+39.40%
Current year+41.18%
1 week 8,457.5
Extreme 8457.5
9,043
1 month 7,220.5
Extreme 7220.5
9,043
Current year 5,647.5
Extreme 5647.5
9,043
1 year 5,636.5
Extreme 5636.5
9,043
3 years 3,295.3
Extreme 3295.3
9,043
5 years 2,730
Extreme 2730
9,043
10 years 532.65
Extreme 532.65
9,043
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+3.21%+5.43%+45.79%+148.40% 24.35B
-1.67%-6.19%+63.19%+116.84% 1,100B
-0.54%-1.24%+52.99%+64.35% 658B
-1.36%-2.07%+25.00%+76.67% 470B
-0.82%+0.30%+42.17%+42.20% 372B
-0.14%+0.11%+25.65%+40.68% 304B
-1.58%+1.49%+3.02%+13.20% 264B
-0.30%-0.87%+51.43%+70.93% 239B
+0.05%+2.10%-12.88%-52.71% 213B
+0.39%+0.37%+29.10%+92.29% 184B
Average -0.29%+2.89%+32.55%+61.28% 382.72B
Weighted average by Cap. -0.92%+2.21%+40.87%+69.18%

Financials

2027 *2028 *
Net sales 126B 1.32B 1.13B 1.06B 967M 1.82B 1.84B 12.48B 4.86B 63.4B 4.95B 4.84B 210B 150B 1.57B 1.35B 1.26B 1.15B 2.18B 2.2B 14.89B 5.8B 75.62B 5.9B 5.77B 250B
Net income 32.57B 342M 293M 274M 251M 473M 478M 3.24B 1.26B 16.43B 1.28B 1.25B 54.42B 39.37B 413M 354M 332M 303M 572M 577M 3.91B 1.52B 19.86B 1.55B 1.52B 65.77B
Net Debt -35B -367M -315M -295M -269M -508M -513M -3.48B -1.35B -17.66B -1.38B -1.35B -58.48B -44.85B -470M -403M -378M -345M -651M -658M -4.46B -1.73B -22.63B -1.77B -1.73B -74.94B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
26/08/26 9,025.00 +3.21% 708,128
25/08/26 ₹8,744.50 +2.92% 563,721
24/08/26 ₹8,496.00 -1.17% 251,013
21/08/26 ₹8,597.00 +0.32% 180,697
20/08/26 ₹8,570.00 +0.12% 198,190
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,744.50INR
Average target price
8,292.48INR
Spread / Average Target
-5.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock